This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a Université Laval directory, so their courses may be missing. Find their university profile.
Research
Latest papers
Recent Advances in Therapeutics and Manufacturing Processes of Recombinant Adeno-Associated Virus for the Treatment of Lung Diseases.
Current gene therapy · 2025 · senior author
Amphiphilic shuttle peptide delivers base editor ribonucleoprotein to correct the CFTR R553X mutation in well-differentiated airway epithelial cells.
Nucleic acids research · 2024
Enhancing peptide and PMO delivery to mouse airway epithelia by chemical conjugation with the amphiphilic peptide S10.
Molecular therapy. Nucleic acids · 2024
Latest funding
- $300,000
The Pursuit of a SARS-CoV-2 Vaccine: Aiming for Broad Protection
CIHR · 2024 · Co-investigator
- $50,000
Study on the fate of viruses in wastewater and sludge treatment using membrane bioreactors and anaerobic digestion within the context of the COVID-19 pandemic_x000d_ _x000d_ _x000d_ _x000d_
NSERC · 2020 · Co-investigator
- $1,650,000
Process Engineering of Emerging Nano-Medicines (PrEEmiuM)
NSERC · 2018 · Co-investigator
20 publications.
Recent Advances in Therapeutics and Manufacturing Processes of Recombinant Adeno-Associated Virus for the Treatment of Lung Diseases.
Sorroza-Martinez L, Pelletier M, Guay D, Gaillet B
Amphiphilic shuttle peptide delivers base editor ribonucleoprotein to correct the CFTR R553X mutation in well-differentiated airway epithelial cells.
Kulhankova K, Cheng AX, Traore S, Auger M, Pelletier M, Hervault M, Wells KD, Green JA, Byrne A, Nelson B, Sponchiado M, Boosani C, Heffner CS, Snow KJ, Murray SA, Villacreses RA, Rector MV, Gansemer ND, Stoltz DA, Allamargot C, Couture F, Hemez C, Hallée S, Barbeau X, Harvey M, Lauvaux C, Gaillet B, Newby GA, Liu DR, McCray PB, Guay D
Enhancing peptide and PMO delivery to mouse airway epithelia by chemical conjugation with the amphiphilic peptide S10.
Auger M, Sorroza-Martinez L, Brahiti N, Huppé CA, Faucher-Giguère L, Arbi I, Hervault M, Cheng X, Gaillet B, Couture F, Guay D, Soultan AH
Improved Manufacturing Methods of Extracellular Vesicles Pseudotyped with the Vesicular Stomatitis Virus Glycoprotein.
Champeil J, Mangion M, Gilbert R, Gaillet B
Impact of Recombinant VSV-HIV Prime, DNA-Boost Vaccine Candidates on Immunogenicity and Viremia on SHIV-Infected Rhesus Macaques.
Berger A, Pedersen J, Kowatsch MM, Scholte F, Lafrance MA, Azizi H, Li Y, Gomez A, Wade M, Fausther-Bovendo H, de La Vega MA, Jelinski J, Babuadze G, Nepveu-Traversy ME, Lamarre C, Racine T, Kang CY, Gaillet B, Garnier A, Gilbert R, Kamen A, Yao XJ, Fowke KR, Arts E, Kobinger G
PEGylation of a Peptide-Based Amphiphilic Delivery Agent and Influence on Protein Delivery to Cells.
Greschner AA, Brahiti N, Auger M, Hu L, Soleymani Abyaneh H, Barbeau X, Parent V, Gaillet B, Guay D, Soultan AH, Gauthier MA
Inducible HEK293 AAV packaging cell lines expressing Rep proteins.
Jalšić L, Lytvyn V, Elahi SM, Hrapovic S, Nassoury N, Chahal PS, Gaillet B, Gilbert R
Purification of recombinant vesicular stomatitis virus-based HIV vaccine candidate.
Bakhshizadeh Gashti A, Chahal PS, Gaillet B, Garnier A
Oleic acid based experimental evolution of Bacillus megaterium yielding an enhanced P450 BM3 variant.
Vincent T, Gaillet B, Garnier A
Production and Use of Gesicles for Nucleic Acid Delivery.
Mangion M, Robert MA, Slivac I, Gilbert R, Gaillet B
The Pursuit of a SARS-CoV-2 Vaccine: Aiming for Broad Protection
Principal investigators: Leclerc, Denis
Keywords: Flexuous Rod Shape Nanoparticle; Humoral And T Cell Immune Response; Sars-C0v-2 Kp.3 Variant; Sars-Cov-2 Nucleocapsid; Sars-Cov-2 Receptor Binding Domain; Sars-Cov-2 Vaccine; Sorties Mediated Coupling; Toll Like Receptor 7/8 Agonist; Vaccine Platform; Vaccine With Broad Protection
Study on the fate of viruses in wastewater and sludge treatment using membrane bioreactors and anaerobic digestion within the context of the COVID-19 pandemic_x000d_ _x000d_ _x000d_ _x000d_
Principal investigators: Vaneeckhaute, Céline
Process Engineering of Emerging Nano-Medicines (PrEEmiuM)
Principal investigators: DeCrescenzo, Gregory
Development of a safe, effective and clinically acceptable VSV-based HIV vaccine
Principal investigators: Kobinger, Gary P
Keywords: Cgmp Cell Lines; Enhanced Immunogenicity; Enhanced Production; Hiv Vaccine; Rhesus Macaques; Vsv Vector
Bio-sourced reagents for the flotation of minerals in the mining industry
Principal investigators: Garnier, Alain
12ième Colloque de l'Association de Thérapie Génique du Québec (ATGQ)
Principal investigators: Gaillet, Bruno
Keywords: Cancer; Essais Cliniques; Interaction Société - Thérapie Génique; Maladies Héréditaires; Production De Vecteurs Viraux; Technologies D'Édition Du Génome; Thérapie Génique
Développement d'un traitement post exposition des infections par le virus Ébola à partir de vecteurs AAV et du sérum ZMapp
Principal investigators: Gaillet, Bruno
Keywords: Anticorps Monoclonaux; Cocktail Zmapp; Essais Précliniques; Génie Biochimique; Procédés De Production Et De Purification De Raav; Recherches Multidisciplinaires; Sciences De La Santé; Thérapie Génique; Traitement Contre Les Infections Humaines Du Virus Ébola; Vecteurs Recombinants Dérivés Du Virus Adéno-Associé (Raav)
Élaboration d'un procédé de production de cellules thérapeutiques autologues destiné au traitement de la Dystrophie musculaire de Duchenne
Principal investigators: Gaillet, Bruno
Development of a technology to monitor viability and stability of probiotics compounds
Principal investigators: Gaillet, Bruno
Élaboration d'un procédé de production de cellules thérapeutiques autologues destiné au traitement de la Dystrophie musculaire de Duchenne
Principal investigators: Gaillet, Bruno; Tremblay, Jacques P
Keywords: Cellules Souches Pluripotentes Induites; Dystrophie Musculaire De Duchenne; Développement De Milieux De Culture; Génie Biochimique 1802; Particules Pseudo Virales; Produits Pharmaceutiques Administrables À L'Homme 504; Sciences De La Santé 9000; Sciences De La Vie (Y Compris Biotechnologie) 1201; Thérapie Cellulaire; Transfection De Protéines
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
Frequent collaborators
- Gary Kobinger and Gary Kobinger: 7 shared papers
- Bruno Gaillet and Amine Kamen: 4 shared papers
- Bruno Gaillet and Gary Kobinger: 2 shared papers
- Gary Kobinger and Amine Kamen: 2 shared papers
- Bruno Gaillet and Xiangguo Qiu: 1 shared paper
- Bruno Gaillet and Gary Kobinger: 1 shared paper
- Bruno Gaillet and Eric Arts: 1 shared paper
- Xiangguo Qiu and Gary Kobinger: 1 shared paper
- Xiangguo Qiu and Gary Kobinger: 1 shared paper
- Xiangguo Qiu and Amine Kamen: 1 shared paper
- Eric Arts and Amine Kamen: 1 shared paper
- Génie chimique
- Bioengineering
- Microbiologie et d'infectiologie
- Microbiology and Immunology
- Medical Microbiology
- Lady Davis Institute for Medical Research
Co-authors at Université Laval, colored by department. Thicker lines mean more shared papers; select anyone to open their profile and their own map.
Amine Kamen
Bioengineering
4 shared papers, latest 2024
Gary Kobinger
Microbiologie et d'infectiologie
2 shared papers, latest 2020
Xiangguo Qiu
Lady Davis Institute for Medical Research
1 shared papers, latest 2018
Gary Kobinger
Medical Microbiology
1 shared papers, latest 2018
Eric Arts
Microbiology and Immunology
1 shared papers, latest 2024
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.